Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 2, Number 2—April 1996

Nosocomial Transmission of Multidrug-Resistant Mycobacterium tuberculosis in Spain

John V. Rullán*, Dionisio Herrera*, Rosa Cano*, Victoria Moreno†, Pere Godoy*, Enrique F. Peiró*, Juan Castell*, Consuelo Ibañez*, Arturo Ortega†, Leopoldo Sánchez Agudo†, and Francisco Pozo‡
Author affiliations: Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo *Programa de Epidemiología Aplicada de Campo-Centro Nacional de Epidemiología; †Centro Nacional de Investigación Clínica y Medicina Preventiva; ‡Subdirección General de Salud, Madrid, Spain

Main Article

Table 2

Population characteristics: case control study

Variable Case patients (%)
n = 18 Control patients (%)
n = 17 OR (95% CI)a
Mean age (yr) 34.4 35.2 p = 0.30b
Male sex 13 (72.2) 14 (82.3) 1.8 (0.3-12.1)
IVDU 11 (61.1) 11 (64.7) 1.2 (0.2-6.7)
Interval HIV to TB
diagnosis in days 1403 1293 p = 0.79b
CD4 lymphocyte
count, median 112.9 199.5 p = 0.30b

a OR (95% CI) = odds ratio (95% confidence intervals); Fisher’s Exact Test.
b p value for analysis of variance (ANOVA). IVDU = intravenous drug user.

Main Article

Page created: December 20, 2010
Page updated: December 20, 2010
Page reviewed: December 20, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.